'Open-Label, Study to Evaluate Eff and Safety of Sofosbuvir/Ledipasvir FDC + RBV for 12 Wks in Chronic Geno 1 HCV Subjects Who Participated in Prior Gilead-Sponsored HCV Tx study'

Biotechnology Computer Science Energy Engineering Environmental Sciences Information Science Life Sciences Mathematics Medical Sciences

Military Sciences Natural Sciences Physical Sciences Plant Sciences Science Space Sciences Technology Transportation